Qrono and Phebra will develop longacting injectable products based on the QronoMetrics platform with a primary focus on psychiatryPITTSBURGH PA PRWEB May 05 2016 Qrono Inc. a specialty pharmaceutical company focused on longacting injectables LAIs today an...